Twist Bioscience revenue and financials
$205.00Change from previous close: +8.66%Absolute change: +$16.33
In the fiscal year ended September 2025, Twist Bioscience reported revenue of $376.57M (+20.32% year over year). The net loss was $77.67M.
Fiscal year ending in September. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +20.32%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- -20.6%
- FY to Sep 2024: -66.7%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 118 | 111 | 104 | 99.0 | 96.1 | 92.8 | 88.7 | 84.7 | 81.5 | 75.3 | 71.5 | 66.9 |
| Cost of revenue | 55.9 | 53.6 | 49.7 | 48.2 | 44.8 | 46.8 | 45.9 | 46.5 | 46.2 | 44.4 | 42.5 | 42.4 |
| Gross profit | 62.5 | 57.1 | 54.0 | 50.8 | 51.3 | 46.0 | 42.8 | 38.2 | 35.3 | 30.9 | 29.0 | 24.5 |
| Selling, general and administrative | 80.7 | 76.1 | 69.7 | 63.8 | 63.4 | 63.7 | 56.2 | 53.1 | 56.8 | 55.6 | 52.8 | 47.4 |
| Research and development | 18.0 | 19.7 | 17.1 | 17.0 | 18.0 | 23.9 | 21.3 | 21.1 | 22.5 | 24.1 | 23.1 | 23.7 |
| Operating income | -36.3 | -38.7 | -32.9 | -29.9 | -30.1 | -41.6 | -34.6 | -36.0 | -44.0 | -48.9 | -47.0 | -46.6 |
| EBIT | -36.3 | -38.7 | -32.9 | -29.9 | -30.1 | -41.6 | -34.6 | -36.0 | -44.0 | -48.9 | -47.0 | -46.6 |
| EBITDA | -29.8 | -32.4 | -27.0 | -26.0 | -24.4 | -35.4 | -28.6 | -32.0 | -35.7 | -40.6 | -38.8 | -39.0 |
| Interest expense | — | — | — | — | — | 0.1 | — | — | — | — | — | 0.0 |
| Pre-tax income | -34.7 | -44.0 | -30.3 | -26.9 | 20.6 | -39.2 | -31.5 | -34.8 | -85.4 | -45.1 | -42.9 | -46.5 |
| Income tax | 0.3 | 0.0 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | -0.1 | 0.2 | 0.3 | 0.1 | -0.2 |
| Net income | -35.1 | -44.0 | -30.5 | -27.1 | 20.4 | -39.3 | -31.6 | -34.7 | -85.6 | -45.5 | -43.0 | -46.2 |
| Net income to common shareholders | -35.1 | -44.0 | -30.5 | -27.1 | 20.4 | -39.3 | -31.6 | -34.7 | -85.6 | -45.5 | -43.0 | -46.2 |
| Basic EPS | -0.56 | -0.71 | -0.50 | -0.45 | 0.34 | -0.66 | -0.53 | -0.59 | -1.47 | -0.79 | -0.75 | -0.81 |
| Diluted EPS | -0.56 | -0.71 | -0.50 | -0.45 | 0.33 | -0.66 | -0.53 | -0.59 | -1.47 | -0.79 | -0.75 | -0.81 |
| Average shares (basic) | 62.4 | 61.7 | 61.1 | 60.4 | 60.0 | 59.6 | 59.2 | 58.6 | 58.1 | 57.8 | 57.5 | 57.3 |
| Average shares (diluted) | 62.4 | 61.7 | 61.1 | 60.4 | 61.2 | 59.6 | 59.2 | 58.6 | 58.1 | 57.8 | 57.5 | 57.3 |